Overview
Jingsong He practices in Hangzhou, China. He is rated as an Advanced expert by MediFind in the treatment of Leukemia. Their top areas of expertise are Multiple Myeloma, Acute Monoblastic Leukemia (AmoL), Leukemia, Bone Marrow Transplant, and Splenectomy.
Their clinical research consists of co-authoring 162 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 27 articles in the study of Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bone Marrow Transplant
- Distinguished
- Multiple MyelomaHe isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Monoblastic Leukemia (AmoL)
- Acute Myeloid Leukemia (AML)
- Cytomegalic Inclusion Disease
- Cytomegalovirus Infection
- LeukemiaHe isAdvanced. Learn about Leukemia.
- Experienced
- Acute Promyelocytic Leukemia
- Anaplastic Large Cell Lymphoma
- AnemiaHe isExperienced. Learn about Anemia.
- B-Cell LymphomaHe isExperienced. Learn about B-Cell Lymphoma.
- Graft Versus Host Disease (GvHD)
- Hemophagocytic Lymphohistiocytosis